跳至主要内容
临床试验/NL-OMON46477
NL-OMON46477已完成不适用

Facioscapulohumeral muscular dystrophy (FSHD): Advanced diagnostics and extended molecular insights - Advanced FSHD diagnostics

eids Universitair Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.FSHD patients:
  • - 18 years or older
  • - Genetically proven FSHD or;
  • - Clinical FSHD diagnosis and permission for genetic testing to confirm the diagnosis;2. Healthy volunteers
  • - 18 years or older;3. Patients with an unrelated neuromuscular disease
  • - 18 years or older
  • - Confirmed neuromuscular disease, like Inclusion Body Myositis (IBM), Ocular pharyngeal muscular dystrophy (OPMD), Myasthenia Gravis (MG) and Lambert Eaton Myasthenic Syndrome (LEMS)

排除标准

  • Healthy volunteers: In order to be eligible to participate in this study, a healthy control must not have:
  • - A muscle disorder
  • - A neurological disorder
  • - A history of a urinary tract disorder interfering with urine sample acquisition

研究者

相似试验

Facioscapulohumeral muscular dystrophy (FSHD):... | 临床试验